Australia markets open in 6 hours 23 minutes
  • ALL ORDS

    6,784.30
    -33.80 (-0.50%)
     
  • AUD/USD

    0.6789
    -0.0011 (-0.15%)
     
  • ASX 200

    6,594.50
    -34.80 (-0.52%)
     
  • OIL

    97.93
    -1.57 (-1.58%)
     
  • GOLD

    1,735.80
    -28.10 (-1.59%)
     
  • BTC-AUD

    29,827.63
    +627.46 (+2.15%)
     
  • CMC Crypto 200

    438.05
    +2.53 (+0.58%)
     

BPH Energy Limited (BPH.AX) Investee Advent Energy Appeal re PEP 11 Permit Extension

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·2-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
BPH Energy Limited
BPH Energy Limited

BPH Energy Limited (BPH.AX) Investee Advent Energy Appeal re PEP 11 Permit Extension

Perth, Australia, June 2, 2022 - (ABN Newswire) - BPH Energy Limited (ASX:BPH) advises that investee Advent Energy Limited's (BPH 36.1% direct interest) 100% subsidiary Asset Energy Pty Ltd has applied to the Federal Court pursuant to section 5 of the Administrative Decisions (Judicial Review) Act 1977 (Cth) and section 39B of the Judiciary Act 1903 (Cth) to review the decision of the Commonwealth-New South Wales Offshore Petroleum Joint Authority (Joint Authority), constituted under section 56 of the Offshore Petroleum and Greenhouse Gas Storage Act 2006 (Cth) (Act), to refuse to vary and suspend the conditions of Exploration Permit for Petroleum No.11 (PEP 11 Permit), pursuant to section 264(2) of the Act, and to refuse to extend the term of the PEP 11 Permit, pursuant to section 265 of the Act. The application was made in December 2019.

Asset Energy Pty Ltd is a 100 % owned subsidiary of Advent Energy Ltd and has lodged the appeal as Operator for and on behalf of the PEP11 Joint Venture Partners, Bounty Oil and Gas NL (ASX:BUY) and Asset Energy Pty Ltd.


About BPH Energy Limited:


BPH Energy Limited (ASX:BPH) is an Australian Securities Exchange listed company developing biomedical research and technologies within Australian Universities and Hospital Institutes.

The company provides early stage funding, project management and commercialisation strategies for a direct collaboration, a spin out company or to secure a license.

BPH provides funding for commercial strategies for proof of concept, research and product development, whilst the institutional partner provides infrastructure and the core scientific expertise.

BPH currently partners with several academic institutions including The Harry Perkins Institute for Medical Research and Swinburne University of Technology (SUT).

Contact:

David Breeze
admin@bphenergy.com.au
www.bphenergy.com.au
T: +61 8 9328 8366

Source:
BPH Energy Limited

Copyright (C) 2022 ABN Newswire. All rights reserved.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting